ARCHIVES
VOL. 11, ISSUE 2 (2025)
Histopathologic biomarkers in breast cancer diagnosis
Authors
Anakwe V Ikechukwu, Abigail Biya, Solomon M Gamde, Akinwale T Ogundipe, Bola D Oyedun
Abstract
Tumor biomarkers are products which are
secreted either by the tumor or are produced by the body during the formation
and progression of the tumors, they have been proven efficient and hopeful in
cancer screening, early detection, risk assessment, recurrence and response to
treatment. The function
of molecular markers has become crucial in diagnosing metastatic breast cancer for appropriate treatment modalities. Commonly used histopathology biomarkers
in breast cancer diagnosis include eestrogen
receptor, progesterone receptor, and human epidermal growth factor receptor 2. These biomarkers provide the right plan of action for treating patients with breast cancer. The
rise in molecular understanding of breast cancer and reference point therapy has led to the present review on histopathology biomarkers
to improve the evolution of personalized treatments.
Download
Pages:9-15
How to cite this article:
Anakwe V Ikechukwu, Abigail Biya, Solomon M Gamde, Akinwale T Ogundipe, Bola D Oyedun "Histopathologic biomarkers in breast cancer diagnosis". International Journal of Medical and Health Research, Vol 11, Issue 2, 2025, Pages 9-15
Download Author Certificate
Please enter the email address corresponding to this article submission to download your certificate.